We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Former Center for Devices and Radiological Health (CDRH) Director David Feigal has landed a job in the private sector with NDA Partners, a Falls Church, Va.-based product development consultancy with a focus on the biopharmaceutical and medical device industries.
Avoiding cultural excesses that lead to unnecessary testing and documentation is paramount in conducting an effective validation process, according to regulatory expert and consultant Ray Miller.
A botched series of inspections may be to blame for the budding rift between the FDA and Utah Medical Products (UTMD), according to Edward McDonnell, the former district director of the FDA’s New England District.
The two national associations that represent drug wholesalers have joined the war against counterfeit drugs by implementing stringent new membership and licensing requirements.
Pfizer has directed its authorized wholesalers and distributors in Canada to stop supplying the company’s drugs to a number of pharmacies that sell the products to patients in the U.S. through internet sites or other means.